MYDA Advisors’s Aveanna Healthcare AVAH Stock Holding History

MYDA Advisors’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,000	Closed	-$495K	–	265
2021 Q2	$495K	Buy	+40,000	New	+$474K	0.12%	186

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

MYDA Advisors's AVAH Position: Q3 2021 in Review

MYDA Advisors sold out of Aveanna Healthcare (AVAH) in Q3 2021, closing a stake of 40,000 shares — an estimated $495K sold.

MYDA Advisors first reported a position in AVAH in Q2 2021 and held it in 1 quarter. The position peaked at $495K in Q2 2021. 87 funds tracked by Wall St. Rank hold AVAH as of Q3 2021.

MYDA Advisors reported no remaining Aveanna Healthcare position as of Q3 2021 after selling out during the quarter.
MYDA Advisors sold 40,000 Aveanna Healthcare shares in Q3 2021, an estimated $495K.
MYDA Advisors first reported a position in Aveanna Healthcare in Q2 2021 and held it in 1 quarter.
MYDA Advisors's Aveanna Healthcare position peaked at $495K in Q2 2021.
87 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q3 2021.

Based on MYDA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.